RAT TGN38 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-RAT TGN38 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RAT TGN38 |
| Clone | polyclonal |
| Host Species | Sheep |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | unconjugated |
| Size | 0.025 mg |
| Concentration | IgG concentration 0.1 mg/ml |
| Applications | Immunohistology Frozen, Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Sheep anti Rat TGN38 antibody recognizes rat TGN38, a 357 amino acid single pass trans membrane glycoprotein found primarily in the Trans-golgi network, and acts as an excellent marker for this cellular organelle (Humphrey et al. 1993). TGN38 is likely to have a role in intracellular transport (McNamara et al. 2004) and plays a role in morphological maintenance (Girotti and Banting 1996). It is the homologue of human TGN46 and macaque TGN47 (Ponnambalam et al. 1996). |
| Immunogen | Buffer Solution: Phosphate buffered saline Antiserum Preparation: Antisera to rat TGN38 were raised by repeated immunisation of sheep with highly purified antigen. Purified IgG prepared by affinity chromatography. Target Species: Rat |
| Other Names | [trans-Golgi network integral membrane protein TGN38; Trans-Golgi network integral membrane protein TGN38; trans-Golgi network integral membrane protein TGN38; trans-golgi network protein 1; trans-golgi network protein 2], [Tgoln2; Ttgn1; Tgn38; Ttgn1; Tgoln1] |
| Gene, Accession # | [TGN38], Gene ID: 192152, NCBI: NP_620195.1, UniProt: P19814 |
| Catalog # | MBS223178 |
| Price | $610 |
| Order / More Info | RAT TGN38 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies